Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Dorr

Showing results (11-20 of 156) with videos related to

Pageof 16
Sort By:
Blood Reviews|March 1, 1990
Antidotes to vesicant chemotherapy extravasationsR T Dorr
Seminars in Radiation Oncology|October 31, 1998
Radioprotectants: pharmacology and clinical applications of amifostineR T Dorr
Drugs|February 1, 1993
Interferon-alpha in malignant and viral diseases. A reviewR T Dorr
Seminars in Oncology|August 1, 1996
Cytoprotective agents for anthracyclinesR T Dorr
Seminars in Oncology|April 1, 1992
Bleomycin pharmacology: mechanism of action and resistance, and clinical pharmacokineticsR T Dorr
Annals of Internal Medicine|September 1, 1978
The current status of laetrileR T Dorr, J Paxinos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Dosing error in protocol bookR T Dorr, D Lauper
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Interaction between cisplatin and mesna in miceR T Dorr, K Lagel
Chemico-Biological Interactions|November 1, 1994
Effect of sulfhydryl compounds and glutathione depletion on rat heart myocyte toxicity induced by 4-hydroperoxycyclophosphamide and acrolein in vitroR T Dorr, K Lagel
Cancer Chemotherapy and Pharmacology|January 1, 1995
Antidote studies of vinorelbine-induced skin ulceration in the mouseR T Dorr, K L Bool
Pageof 16

Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
Blood Reviews|March 1, 1990
Antidotes to vesicant chemotherapy extravasationsR T Dorr
Seminars in Radiation Oncology|October 31, 1998
Radioprotectants: pharmacology and clinical applications of amifostineR T Dorr
Drugs|February 1, 1993
Interferon-alpha in malignant and viral diseases. A reviewR T Dorr
Seminars in Oncology|August 1, 1996
Cytoprotective agents for anthracyclinesR T Dorr
Seminars in Oncology|April 1, 1992
Bleomycin pharmacology: mechanism of action and resistance, and clinical pharmacokineticsR T Dorr
Annals of Internal Medicine|September 1, 1978
The current status of laetrileR T Dorr, J Paxinos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Dosing error in protocol bookR T Dorr, D Lauper
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Interaction between cisplatin and mesna in miceR T Dorr, K Lagel
Chemico-Biological Interactions|November 1, 1994
Effect of sulfhydryl compounds and glutathione depletion on rat heart myocyte toxicity induced by 4-hydroperoxycyclophosphamide and acrolein in vitroR T Dorr, K Lagel
Cancer Chemotherapy and Pharmacology|January 1, 1995
Antidote studies of vinorelbine-induced skin ulceration in the mouseR T Dorr, K L Bool
Pageof 16